#Sweden #Lund #BPC Instruments #Biogas #Eiffel Investment Group

BPC Instruments Announces Directed Share Issue

BPC Instruments AB (publ), a leading technology company in renewable bioenergy and environmental biotechnology, has made a significant announcement regarding its financial maneuvering to bolster its operations and strategic presence. The company's Board of Directors has approved a directed share issue amounting to approximately SEK 24.5 million, aimed primarily at institutional investor Eiffel Investment Group. This directive is pending approval from an upcoming Extraordinary General Meeting scheduled for February 12, 2025.

Strategic Intent Behind the Share Issue

The primary goal of this directed share issue is to broaden the international shareholder base for BPC Instruments. By collaborating with Eiffel Investment Group, which has a profound expertise in energy transition and biogas sectors, BPC aims to accelerate its strategic initiatives related to sustainability, renewable energy technologies, and environmental governance (ESG) factors. CEO Jing Liu emphasized the importance of this partnership, noting that Eiffel's commitment to green investment aligns perfectly with BPC's operational focus.

Laurent Inglebert, a Director at Eiffel Investment Group, expressed strong confidence in BPC's potential, citing the company's innovative analytical instruments that enhance resource management and energy extraction within the biogas ecosystem. This affluent partnership signals a pivotal movement towards strategic international growth for BPC, particularly in the European biomethane market.

Details of the Directed Share Issue

The directed share issue includes 650,300 new shares priced at SEK 37.6 per share, reflecting a slight premium over the recent average market value. The total expected capital raised before transaction related costs is estimated at SEK 24.5 million. Major shareholders, representing approximately 73.4% of votes in BPC Instruments, have already expressed their intention and entered agreements to support this resolution in the upcoming meeting.

To facilitate this issue, shares will be temporarily subscribed by Nordic Issuing AB, later transferring these shares to Eiffel at the agreed price. A concurrent Block Trade will see Eiffel acquiring additional shares, augmenting the synergy between the two entities. This transaction is designed to maintain market stability and protect existing shareholders' interests.

Evaluating Alternatives

BPC's Board underwent extensive deliberation regarding different capital-raising avenues, ultimately favoring the directed share issue over a more complex rights issue. Key points of consideration included the time efficiency, lower execution costs, and broader long-term benefits inherent in a directed approach. The latter aims to solidify a more robust institutional investor framework which enhances overall liquidity for BPC’s shares.

Impact on Share Capital

This maneuver will slightly dilute existing shareholders, but it promises to pave the way for increased institutional engagement in the company's growth trajectory. Post-issue, the total share capital will rise to SEK 610,736.5, and total shares will increment to 11,104,300. Eiffel's resultant stake will stand at approximately 8.37%, underlining their commitment and pivotal role in BPC's evolving narrative.

Conclusion

The directed share issue by BPC Instruments, in collaboration with Eiffel Investment Group, marks a transformative step aimed at enhancing the company's operational capacity and expanding its market footprint. As the energy landscape continuously evolves towards sustainable alternatives, this strategic partnership holds promise not just for BPC, but for stakeholders committed to driving impactful environmental technologies. The focus on innovations in the biogas sector inevitably reinforces BPC's position as a pioneer in renewable energy technologies.

For ongoing developments, stakeholders and potential investors are encouraged to keep abreast of news pertaining to the extraordinary general meeting and further regulatory clarifications from BPC Instruments.

Contact Information:
Dr. Jing Liu, CEO
BPC Instruments AB
Tel: +46 (0)46 16 39 51
Email: [email protected]

For more information about BPC Instruments, visit their official website: www.bpcinstruments.com